Seelos Therapeutics, Inc. Made Big Gain

Fri, May 15, 2020 at 05:34 PM

Seelos Therapeutics, Inc. (SEEL:NASDAQ) jumped higher at $0.97, representing a gain of 31.1%. The stock got featured on our News Catalysts scanner on Fri 15 May 20 at 11:29 AM in the 'INVESTOR UPDATE' category. From Thu 30 Apr 20, the stock recorded 50.00% Up Days and 54.55% Green Days

The stock spiked on Thu 30 Apr 20 at $0.87 with a volume of 10M+, and its share price has been moving sideways in recent weeks.

About Seelos Therapeutics, Inc. (SEEL:NASDAQ)

Apricus Biosciences Inc is engaged in the pharmaceutical industry. The company develops and commercializes products and product candidates in the areas of urology and rheumatology. Apricus' drug delivery technology is a permeation enhancer called NexACT. The company has over two product candidates in Phase II development, fispemifene for the treatment of symptomatic male secondary hypogonadism and RayVa for the treatment of Raynaud's phenomenon.

Top 10 Gainers:

Sorrento Therapeutics, Inc. (SRNE:NASDAQ), 158.02%
Aurora Cannabis Inc. (ACB:NYSE), 68.67%
Torchlight Energy Resources, Inc. (TRCH:NASDAQ), 48.28%
Sundial Growers Inc. (SNDL:NASDAQ), 42.08%
Alta Equipment Group Inc. (ALTG:NYSE), 35.27%
Tenax Therapeutics, Inc. (TENX:NASDAQ), 33.63%
Tetraphase Pharmaceuticals, Inc. (TTPH:NASDAQ), 33.54%
CRDF (CRDF:NASDAQ), 32.87%
Diffusion Pharmaceuticals Inc. (DFFN:NASDAQ), 32.35%
Seelos Therapeutics, Inc. (SEEL:NASDAQ), 31.08%